Spanish Hematology Registry: World Leader in Fragility
- * Spain is a leader in geriatric assessment in hematology: Spain is considered a pioneering country and international reference in this field.
Here are the facts from the provided text:
* Spain is a leader in geriatric assessment in hematology: Spain is considered a pioneering country and international reference in this field.
* Spanish Registry of Hematogeriatrics: This is a collaborative project by the Spanish Society of Hematology and Hemotherapy (SEHH).
* Focus on Frailty & Functional Assessment: The registry systematically integrates frailty assessment and functional assessment in older patients with hematological diseases.
* Raúl Córdoba: He is a member of the Board of Directors of the SEHH and spoke to Medical Writng about the registry.
* Registry Study Details: The registry is a multicenter, prospective, and observational study. It included 285 patients aged 70 or older with hematological malignancies.
* GAH Scale: The escala GAH (Geriatric Assessment in Hematology) is useful as a prognostic tool, allowing for patient stratification based on functional status and frailty.
* Age is not the sole factor: Chronological age alone shouldn’t be the main criterion for deciding treatment for older patients.
* Personalized Care: The registry supports a move towards more personalized care and individualized hematology, adapting treatments based on a patient’s real situation (beyond age).
* Hematogeriatrics is a clinical need: It’s no longer a secondary research area but a recognized clinical need.
* Underrepresented Population: The study focuses on a population traditionally underrepresented in clinical trials (older patients).
* Risk of Treatment Discontinuation: the GAH scale can help identify patients at risk of early discontinuation of treatment.